Florida Scientists Champion ‘Food Is Medicine’ Movement To Tackle National Health Crisis
UF researchers are calling for a national shift in treating fruits and vegetables as medicine, urging integrated solutions across health, agriculture, and food systems to address the growing obesity and Type 2 diabetes crisis.
UF/IFAS Scientists Confirm Hybrid Termites Established in Florida
UF researchers have confirmed that two of the world’s most destructive termite species are hybridizing in South Florida, raising concerns about faster spread and greater damage.
Florida Venture Forum Announces Startups Selected to Present at 2025 Florida Early Stage Venture Conference
Oboro Labs, a UF startup, is among the companies selected to pitch at the 2025 Florida Early Stage Venture Conference, showcasing the innovative technologies emerging from UF’s entrepreneurial ecosystem.
UF/IFAS Study: Drones, AI Help Farmers Save Money, Protect the Environment
UF researchers have used drones and AI-powered imaging to help farmers grow healthier hemp by determining optimal nitrogen fertilizer levels, which saves money and protects the environment.
Researchers Warn of Rise in AI-Created Non-Consensual Explicit Images
UF researchers, with funding from the NSF, have led a study investigating a growing class of tools that allow users to generate realistic nude images from uploaded photos.
UF Health: Timing, Consistency of Activity Linked to Better Fitness
A new UF study, funded by the NIA, shows that the timing and consistency of daily activity may be associated with improved cardiorespiratory fitness and walking efficiency — two key indicators of healthy aging
Water Researchers Develop Prediction System for Harmful Algae
UF researchers have developed a next-day prediction model for harmful algal blooms, providing water managers with timely tools to mitigate environmental and public health risks.
Will Genome Modifications Define Next-Gen AAV Vectors?
UF researcher Arun Srivastava, Ph.D., a gene therapy pioneer, shares his expert perspective on genome-modified AAV vectors, offering insights into how next-generation viral therapies may be shaped by precision genetic engineering.
Atsena Therapeutics Announces Positive Clinical Data From Part A of Phase I/II Trial Evaluating ATSN-201 Gene Therapy To Treat X-Linked Retinoschisis (XLRS)
UF startup Atsena Therapeutics announced positive clinical data results from Part A of the LIGHTHOUSE study, a Phase I/II clinical trial evaluating subretinal injection of ATSN-201 for the treatment of X-linked retinoschisis (XLRS).
Dalir Joins National Effort To Enable 3D Optical Packaging for Next-Gen AI Chips
UF researcher Hamed Dalir, Ph.D., is collaborating on a $5.2 million federally funded project to develop a transformative 3D optical packaging platform that enables scalable, high-bandwidth, energy-efficient chip-to-chip optical communication.